
Sign up to save your podcasts
Or


Mairi McLean talks to Anna Paterson and Rebecca Fitzgerald, both MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, about their study investigating whether a receptor tyrosine kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric adenocarcinomas.
Read the full paper here: bit.ly/1acACwz
By BMJ Group4.1
77 ratings
Mairi McLean talks to Anna Paterson and Rebecca Fitzgerald, both MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, about their study investigating whether a receptor tyrosine kinase (RTK) array could be used to select the most effective therapeutic strategies in molecularly heterogeneous oesophago-gastric adenocarcinomas.
Read the full paper here: bit.ly/1acACwz

138 Listeners

322 Listeners

498 Listeners

37 Listeners

52 Listeners

69 Listeners

5 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

30 Listeners

14 Listeners

3 Listeners

3,339 Listeners

3 Listeners

27 Listeners

1,154 Listeners

192 Listeners

513 Listeners

24 Listeners

369 Listeners

249 Listeners

372 Listeners

17 Listeners

0 Listeners